Literature DB >> 30908280

A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.

Jesse L Berry, Kaitlin Kogachi, A Linn Murphree, Rima Jubran, Jonathan W Kim.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30908280      PMCID： PMC6676476          DOI： 10.1097/IIO.0000000000000269

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  42 in total

1.  Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.

Authors:  Carol L Shields; Fairooz P Manjandavida; Sruthi Arepalli; Swathi Kaliki; Sara E Lally; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

2.  Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results.

Authors:  David H Abramson; Brian P Marr; Ira J Dunkel; Scott Brodie; Emily C Zabor; Sarah J Driscoll; Y Pierre Gobin
Journal:  Br J Ophthalmol       Date:  2011-11-03       Impact factor: 4.638

3.  Pars Plana Vitrectomy and Endoresection of Refractory Intraocular Retinoblastoma.

Authors:  Junyang Zhao; Qiyan Li; Songyi Wu; Liwen Jin; Xiaoli Ma; Mei Jin; Yizhuo Wang; Brenda Gallie
Journal:  Ophthalmology       Date:  2017-11-16       Impact factor: 12.079

4.  Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.

Authors:  Carol L Shields; Arman Mashayekhi; Jacqueline Cater; Abdallah Shelil; Steven Ness; Anna T Meadows; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2005-06

5.  The International Classification of Retinoblastoma predicts chemoreduction success.

Authors:  Carol L Shields; Arman Mashayekhi; Angela K Au; Craig Czyz; Ann Leahey; Anna T Meadows; Jerry A Shields
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

6.  Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.

Authors:  Alec L Amram; Grecia Rico; Jonathan W Kim; Murali Chintagumpala; Cynthia E Herzog; Dan S Gombos; Patricia Chévez-Barrios
Journal:  Ophthalmology       Date:  2017-05-17       Impact factor: 12.079

7.  Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.

Authors:  Jesse L Berry; Rima Jubran; Jonathan W Kim; Kenneth Wong; Simon R Bababeygy; Hashem Almarzouki; Thomas C Lee; A Linn Murphree
Journal:  Pediatr Blood Cancer       Date:  2012-09-19       Impact factor: 3.167

8.  Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.

Authors:  Jesse L Berry; Mercy Bechtold; Sona Shah; Emily Zolfaghari; Mark Reid; Rima Jubran; Jonathan W Kim
Journal:  Ophthalmology       Date:  2017-06-24       Impact factor: 12.079

9.  Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.

Authors:  Carol L Shields; Santosh G Honavar; Jerry A Shields; Hakan Demirci; Anna T Meadows; Thomas John Naduvilath
Journal:  Arch Ophthalmol       Date:  2002-04

10.  Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013.

Authors:  Francis L Munier
Journal:  Ophthalmic Genet       Date:  2014-10-16       Impact factor: 1.803
View more
  5 in total

1.  LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing β-catenin degradation.

Authors:  Yali Gao; Xiaona Chen; Jun Zhang
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

2.  Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-10-25

3.  Response criteria for intraocular retinoblastoma: RB-RECIST.

Authors:  Jesse L Berry; Francis L Munier; Brenda L Gallie; Ashley Polski; Sona Shah; Carol L Shields; Dan S Gombos; Kathleen Ruchalski; Christina Stathopoulos; Rachana Shah; Rima Jubran; Jonathan W Kim; Prithvi Mruthyunjaya; Brian P Marr; Matthew W Wilson; Rachel C Brennan; Guillermo L Chantada; Murali M Chintagumpala; A Linn Murphree
Journal:  Pediatr Blood Cancer       Date:  2021-02-23       Impact factor: 3.167

4.  The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review.

Authors:  J Runnels; G Acosta; A Rose; M Haynes; D Nikolaidis; A Wong; B Fiani
Journal:  Clin Transl Oncol       Date:  2021-04-07       Impact factor: 3.405

5.  Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging.

Authors:  Noy Ashkenazy; J Daniel Diaz; Eric D Hansen; J William Harbou; Zelia M Correa
Journal:  Am J Ophthalmol Case Rep       Date:  2022-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.